| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Blue Key | 2 | The Aff | the Neg |
|
| ||
| Nov-Dec Topic | 2 | Opponent | Judge |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Nov-Dec Topic | 2 | Opponent: Opponent | Judge: Judge NC Positions |
To modify or delete round reports, edit the associated round.
| Entry | Date |
|---|---|
NC Economy DisadvantageTournament: Nov-Dec Topic | Round: 2 | Opponent: Opponent | Judge: Judge Economy NC – GrowthReducing IP protections kills incentives for medical advancements – harms long-term economic growth.James Bacchus, JD, 20 ~Adjunct Fellow @ Cato Institute, JD Florida State University, MA History from Yale, former Congressman from Florida~, "An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines," Cato Institute, 12-16-2020, https://www.cato.org/free-trade-bulletin/unnecessary-proposal-wto-waiver-intellectual-property-rights-covid-19-vaccines C.VC AND of every endeavor of multilateral cooperation in the fight to end this pandemic. Decline of US economic leadership destabilizes the international order and causes extinction.Haas 17 – Richard Haas, President of the Council on Foreign Relations, former Director of Policy Planning for the US State Department (2001-2003), and President George W. Bush's special envoy to Northern Ireland and Coordinator for the Future of Afghanistan. ~A World in Disarray: American Foreign Policy and the Crisis of the Old Order, 1-10-17, Penguin Press~ AND than what it is doing and, more important, not doing.4 | 10/21/21 |
NC Innovation DisadvantageTournament: Nov-Dec Topic | Round: 2 | Opponent: Opponent | Judge: Judge Innovation NC – PandemicsPharmaceutical innovation is accelerating now – new medicines are substantially better than existing treatments.Wills, MBA, and Lipkus, PhD, 20 – Todd J. Wills ~Managing Director @ Chemical Abstracts Service, MBA from THE Ohio State University~ and Alan H. Lipkus ~Senior Data Analyst @ Chemical Abstracts Service, PhD Physical Chemistry from the University of Rochester~, "Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation," ACS Medicinal Chemistry Letters, Vol. 11, 2020, https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00319 C.VC AND never been used as the basis for a molecule) to further explore. The biopharmaceutical industry is uniquely reliant on IP protections – undermining them would kill innovation by making an already expensive process completely unfeasible.Kristina M. Lybecker, PhD, 17 ~PhD Economics, Associate Professor of Economics @ Colorado College~, "Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up," Fraser Institute, January 2017, https://www.fraserinstitute.org/sites/default/files/intellectual-property-rights-protection-and-the20biopharmaceutical-industry.pdf C.VC AND shaping the biopharmaceutical industry, its profitability, productivity, and innovative future. Pharmaceutical innovation is key to protecting against future pandemics, bioterrorism, and antibiotic resistance.Marjanovic and Fejiao ‘20 Marjanovic, Sonja, and Carolina Feijao. Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020). ~Quality Control~ AND health threats to an even greater extent under improved innova-tion conditions. | 10/21/21 |
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
10/30/21 | nathankarlfleming@gmailcom |
| |
10/21/21 | nathankarlfleming@gmailcom |
|